CIC
BEAM icon

Canal Insurance Company’s Beam Therapeutics BEAM Stock Holding History

Canal Insurance Company’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,000
Closed -$953K – 77
2026
Q1 		$953K Buy
+40,000
New +$1.11M 0.2% 62

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Canal Insurance Company's BEAM Position: Q2 2026 in Review

Canal Insurance Company sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 40,000 shares — an estimated $953K sold.

Canal Insurance Company first reported a position in BEAM in Q1 2026 and held it in 1 quarter. The position peaked at $953K in Q1 2026. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Canal Insurance Company reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Canal Insurance Company sold 40,000 Beam Therapeutics shares in Q2 2026, an estimated $953K.
  • Canal Insurance Company first reported a position in Beam Therapeutics in Q1 2026 and held it in 1 quarter.
  • Canal Insurance Company's Beam Therapeutics position peaked at $953K in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.